Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
TL;DR: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update as discussed by the authors .
read more
Abstract: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year's worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year's edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy.Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
02 Aug 2022
TL;DR: In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease treatment to one inclusive of positive health promotion and preservation across the life course in populations and individuals as discussed by the authors .
1.1K
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
TL;DR: A guideline for the management of patients with spontaneous intra-brachial haemorrhage was proposed by the American Heart Association and American Stroke Association as discussed by the authors . But the guideline does not address the treatment of the patients.
704
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
TL;DR: In this paper , the authors focus on elucidating how various endogenous and exogenous stresses (such as genomic instability, telomere dysfunction, epigenetic alterations, loss of proteostasis, compromise of autophagy, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, deregulated nutrient sensing) participate in the regulation of aging.
Status of Cardiovascular Health in US Adults and Children Using the American Heart Association’s New “Life’s Essential 8” Metrics: Prevalence Estimates From the National Health and Nutrition Examination Survey (NHANES), 2013 Through 2018
13 Sep 2022
TL;DR: The Life's Essential 8 score as mentioned in this paper has been used to identify large group and individual differences in cardiovascular disease in the US population and there are both broad and targeted opportunities to monitor, preserve, and improve cardiovascular health across the life course in individuals and the population.
256
Heart Failure With Preserved Ejection Fraction: A Review.
TL;DR: In this paper , the authors proposed a risk factor for heart failure with preserved ejection fraction (HFpEF), defined as HF with an EF of 50% or higher at diagnosis, which affects approximately 3 million people in the US and up to 32 million people worldwide.
252
References
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Adrienne Tin,Jonathan Marten,Victoria L. Halperin Kuhns,Yong Li,Matthias Wuttke,Holger Kirsten,Karsten B. Sieber,Chengxiang Qiu,Mathias Gorski,Mathias Gorski,Zhi Yu,Ayush Giri,Ayush Giri,Gardar Sveinbjornsson,Man Li,Audrey Y. Chu,Anselm Hoppmann,Luke J. O’Connor,Bram P. Prins,Teresa Nutile,Damia Noce,Masato Akiyama,Massimiliano Cocca,Sahar Ghasemi,Peter J. van der Most,Katrin Horn,Yizhe Xu,Christian Fuchsberger,Sanaz Sedaghat,Saima Afaq,Saima Afaq,Najaf Amin,Johan Ärnlöv,Johan Ärnlöv,Stephan J. L. Bakker,Nisha Bansal,Daniela Baptista,Sven Bergmann,Sven Bergmann,Sven Bergmann,Mary L. Biggs,Ginevra Biino,Eric Boerwinkle,Erwin P. Bottinger,Thibaud Boutin,Marco Brumat,Ralph Burkhardt,Ralph Burkhardt,Eric Campana,Archie Campbell,Harry Campbell,Robert J. Carroll,Eulalia Catamo,John C. Chambers,Marina Ciullo,Maria Pina Concas,Josef Coresh,Tanguy Corre,Tanguy Corre,Daniele Cusi,Sala Cinzia Felicita,Martin H. de Borst,Alessandro De Grandi,Renée de Mutsert,Aiko P. J. de Vries,Graciela E. Delgado,Ayse Demirkan,Ayse Demirkan,Olivier Devuyst,Katalin Dittrich,Kai-Uwe Eckardt,Kai-Uwe Eckardt,Georg Ehret,Karlhans Endlich,Michele K. Evans,Ron T. Gansevoort,Paolo Gasparini,Vilmantas Giedraitis,Christian Gieger,Giorgia Girotto,Martin Gögele,Scott D. Gordon,Daniel F. Gudbjartsson,Vilmundur Gudnason,Toomas Haller,Pavel Hamet,Tamara B. Harris,Caroline Hayward,Andrew A. Hicks,Edith Hofer,Hilma Holm,Wei Huang,Nina Hutri-Kähönen,Shih-Jen Hwang,M. Arfan Ikram,Raychel M. Lewis,Erik Ingelsson,Johanna Jakobsdottir,Ingileif Jonsdottir,Helgi Jonsson,Peter K. Joshi,Navya Shilpa Josyula,Bettina Jung,Mika Kähönen,Yoichiro Kamatani,Masahiro Kanai,Shona M. Kerr,Wieland Kiess,Marcus E. Kleber,Wolfgang Koenig,Wolfgang Koenig,Jaspal S. Kooner,Antje Körner,Peter Kovacs,Bernhard K. Krämer,Florian Kronenberg,Michiaki Kubo,Brigitte Kühnel,Martina La Bianca,Leslie A. Lange,Benjamin Lehne,Terho Lehtimäki,Jun Liu,Jun Liu,Markus Loeffler,Ruth J. F. Loos,Leo-Pekka Lyytikäinen,Reedik Mägi,Anubha Mahajan,Anubha Mahajan,Nicholas G. Martin,Winfried März,Winfried März,Winfried März,Deborah Mascalzoni,Koichi Matsuda,Christa Meisinger,Thomas Meitinger,Andres Metspalu,Yuri Milaneschi,Christopher J. O'Donnell,Christopher J. O'Donnell,Otis D. Wilson,J. Michael Gaziano,J. Michael Gaziano,Pashupati P. Mishra,Karen L. Mohlke,Nina Mononen,Grant W. Montgomery,Dennis O. Mook-Kanamori,Martina Müller-Nurasyid,Girish N. Nadkarni,Mike A. Nalls,Matthias Nauck,Kjell Nikus,Boting Ning,Ilja M. Nolte,Raymond Noordam,Jeffrey R. O'Connell,Isleifur Olafsson,Sandosh Padmanabhan,Brenda W.J.H. Penninx,Thomas T. Perls,Annette Peters,Mario Pirastu,Nicola Pirastu,Giorgio Pistis,Ozren Polasek,Belen Ponte,David J. Porteous,Tanja Poulain,Michael Preuss,Ton J. Rabelink,Laura M. Raffield,Olli T. Raitakari,Olli T. Raitakari,Rainer Rettig,Myriam Rheinberger,Kenneth Rice,Federica Rizzi,Antonietta Robino,Igor Rudan,Alena Krajčoviechová,Renata Cifkova,Rico Rueedi,Rico Rueedi,Daniela Ruggiero,Kathleen A. Ryan,Yasaman Saba,Erika Salvi,Helena Schmidt,Reinhold Schmidt,Christian M. Shaffer,Albert V. Smith,Blair H. Smith,Cassandra N. Spracklen,Konstantin Strauch,Michael Stumvoll,Patrick Sulem,Salman M. Tajuddin,Andrej Teren,Joachim Thiery,Chris H. L. Thio,Unnur Thorsteinsdottir,Daniela Toniolo,Anke Tönjes,Johanne Tremblay,André G. Uitterlinden,Simona Vaccargiu,Pim van der Harst,Cornelia M. van Duijn,Cornelia M. van Duijn,Cornelia M. van Duijn,Niek Verweij,Uwe Völker,Peter Vollenweider,Gérard Waeber,Melanie Waldenberger,John Whitfield,Sarah H. Wild,James F. Wilson,Qiong Yang,Weihua Zhang,Weihua Zhang,Alan B. Zonderman,Murielle Bochud,James G. Wilson,Sarah A. Pendergrass,Kevin Ho,Afshin Parsa,Afshin Parsa,Peter P. Pramstaller,Bruce M. Psaty,Bruce M. Psaty,Carsten A. Böger,Harold Snieder,Adam S. Butterworth,Yukinori Okada,Todd L. Edwards,Todd L. Edwards,Kari Stefansson,Katalin Susztak,Markus Scholz,Iris M. Heid,Adriana M. Hung,Adriana M. Hung,Alexander Teumer,Cristian Pattaro,Owen M. Woodward,Veronique Vitart,Anna Köttgen,Anna Köttgen +251 more
TL;DR: A trans-ancestry genome-wide association study of serum urate levels identifies 183 loci that improve the prediction of gout in an independent cohort of 334,880 individuals, and implicates the kidney and liver as key target organs and prioritize potential causal genes.
AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
Lei Chen,Dianna J. Magliano,Beverley Balkau,Beverley Balkau,Stephen Colagiuri,Paul Zimmet,Andrew Tonkin,Paul Mitchell,Patrick P. J. Phillips,Jonathan E. Shaw +9 more
TL;DR: The objective is to develop and validate a diabetes risk assessment tool for Australia based on demographic, lifestyle and simple anthropometric measures.
Biological and clinical insights from genetics of insomnia symptoms
Jacqueline M. Lane,Jacqueline M. Lane,Samuel E. Jones,Hassan S. Dashti,Hassan S. Dashti,Andrew R. Wood,Krishna G. Aragam,Vincent T. van Hees,Linn B Strand,Bendik S. Winsvold,Bendik S. Winsvold,Heming Wang,Heming Wang,Heming Wang,Jack Bowden,Yanwei Song,Yanwei Song,Yanwei Song,Krunal Patel,Krunal Patel,Simon G. Anderson,Simon G. Anderson,Robin N Beaumont,David A. Bechtold,Brian E. Cade,Brian E. Cade,Brian E. Cade,Mary E. Haas,Mary E. Haas,Sekar Kathiresan,Max A. Little,Max A. Little,Annemarie I. Luik,Annemarie I. Luik,Andrew S. I. Loudon,Shaun Purcell,Rebecca C Richmond,Frank A.J.L. Scheer,Frank A.J.L. Scheer,Frank A.J.L. Scheer,Barbara Schormair,Jessica Tyrrell,John W. Winkelman,Juliane Winkelmann,Hunt All In Sleep,Kristian Hveem,Chen Zhao,Jonas B. Nielsen,Cristen J. Willer,Susan Redline,Kai Spiegelhalder,Simon D. Kyle,David W. Ray,David W. Ray,John-Anker Zwart,John-Anker Zwart,Ben Michael Brumpton,Ben Michael Brumpton,Timothy M. Frayling,Debbie A Lawlor,Martin K. Rutter,Martin K. Rutter,Michael N. Weedon,Richa Saxena,Richa Saxena +64 more
TL;DR: Genome-wide association analyses identify 57 loci associated with insomnia symptoms and provide evidence of shared genetic architecture between insomnia and cardiometabolic, behavioral, psychiatric and reproductive traits.
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
Joseph A Salami,Haider J. Warraich,Javier Valero-Elizondo,Erica S. Spatz,Nihar R. Desai,Jamal S. Rana,Salim S. Virani,Ron Blankstein,Amit Khera,Michael J. Blaha,Roger S. Blumenthal,Donald M. Lloyd-Jones,Khurram Nasir,Khurram Nasir +13 more
TL;DR: Statin use increased substantially in the last decade among US adults, although the uptake was suboptimal in high-risk groups, and further substitution of brand-name to generic statins may yield more savings.
347
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke
Ashis H Tayal,Melissa Tian,Kathleen Kelly,S. C. Jones,D. G. Wright,Daljit Singh,J. Jarouse,J. Brillman,S. Murali,Rishi Gupta +9 more
TL;DR: There is a high rate of atrial fibrillation detection by Mobile Cardiac Outpatient Telemetry (21 days) in patients with cryptogenic TIA/stroke that may be related to extended monitoring duration, patient selection, and inclusion of all new onset AF episodes.
346